Has Market Sentiment Shifted on Heliogen?

Heliogen stock is trading -40.0% below its average target price of $0.47 after marking a 12.8% during today's morning session. Analysts are giving the small-cap Utilities—Independent Power Producers company an average rating of hold and target prices ranging from $0.29 to $0.65 per share.

The stock has an average amount of shares sold short at 5.8%, and a short ratio of 1.34. Insiders such as directors and executives own 25.98% of the company's shares, from which we can deduce there is a significant degree of alignment between management and shareholder interests. Finally, we also note that only a small number of institutional investors are invested in the stock, with 40.4% of Heliogen's shares being owned by this investor type.

Institutions Invested in Heliogen

Date Reported Holder Percentage Shares Value
2022-12-31 Prime Movers Lab, LLC 12% 23,945,777 $6,752,709
2022-12-31 Vanguard Group, Inc. (The) 4% 7,062,952 $1,991,752
2022-12-31 Blackrock Inc. 3% 6,179,153 $1,742,521
2022-12-31 Capital World Investors 3% 5,800,000 $1,635,600
2022-12-31 Millennium Management Llc 2% 4,050,345 $1,142,197
2022-12-31 State Street Corporation 1% 2,079,996 $586,558
2022-12-31 Geode Capital Management, LLC 1% 1,628,599 $459,264
2022-12-31 Jane Street Group, LLC 1% 1,579,599 $445,446
2022-12-31 Renaissance Technologies, LLC 1% 1,486,800 $419,277
2022-12-31 Shanda Asset Management Holdings Ltd 1% 1,359,330 $383,331

Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Heliogen.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.